Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatment Market Perspective (2018-2029)
2.2 Global Sickle Cell Disease Treatment Growth Trends by Region
2.2.1 Sickle Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sickle Cell Disease Treatment Historic Market Size by Region (2018-2024)
2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Sickle Cell Disease Treatment Market Dynamics
2.3.1 Sickle Cell Disease Treatment Industry Trends
2.3.2 Sickle Cell Disease Treatment Market Drivers
2.3.3 Sickle Cell Disease Treatment Market Challenges
2.3.4 Sickle Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sickle Cell Disease Treatment by Players
3.1.1 Global Sickle Cell Disease Treatment Revenue by Players (2018-2024)
3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sickle Cell Disease Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2022
3.5 Global Key Players of Sickle Cell Disease Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Disease Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2018-2024)
4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sickle Cell Disease Treatment Market Size (2018-2029)
6.2 North America Sickle Cell Disease Treatment Market Size by Type
6.2.1 North America Sickle Cell Disease Treatment Market Size by Type (2018-2024)
6.2.2 North America Sickle Cell Disease Treatment Market Size by Type (2024-2029)
6.2.3 North America Sickle Cell Disease Treatment Market Share by Type (2018-2029)
6.3 North America Sickle Cell Disease Treatment Market Size by Application
6.3.1 North America Sickle Cell Disease Treatment Market Size by Application (2018-2024)
6.3.2 North America Sickle Cell Disease Treatment Market Size by Application (2024-2029)
6.3.3 North America Sickle Cell Disease Treatment Market Share by Application (2018-2029)
6.4 North America Sickle Cell Disease Treatment Market Size by Country
6.4.1 North America Sickle Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Sickle Cell Disease Treatment Market Size by Country (2018-2024)
6.4.3 North America Sickle Cell Disease Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size (2018-2029)
7.2 Europe Sickle Cell Disease Treatment Market Size by Type
7.2.1 Europe Sickle Cell Disease Treatment Market Size by Type (2018-2024)
7.2.2 Europe Sickle Cell Disease Treatment Market Size by Type (2024-2029)
7.2.3 Europe Sickle Cell Disease Treatment Market Share by Type (2018-2029)
7.3 Europe Sickle Cell Disease Treatment Market Size by Application
7.3.1 Europe Sickle Cell Disease Treatment Market Size by Application (2018-2024)
7.3.2 Europe Sickle Cell Disease Treatment Market Size by Application (2024-2029)
7.3.3 Europe Sickle Cell Disease Treatment Market Share by Application (2018-2029)
7.4 Europe Sickle Cell Disease Treatment Market Size by Country
7.4.1 Europe Sickle Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Sickle Cell Disease Treatment Market Size by Country (2018-2024)
7.4.3 Europe Sickle Cell Disease Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sickle Cell Disease Treatment Market Size (2018-2029)
8.2 China Sickle Cell Disease Treatment Market Size by Type
8.2.1 China Sickle Cell Disease Treatment Market Size by Type (2018-2024)
8.2.2 China Sickle Cell Disease Treatment Market Size by Type (2024-2029)
8.2.3 China Sickle Cell Disease Treatment Market Share by Type (2018-2029)
8.3 China Sickle Cell Disease Treatment Market Size by Application
8.3.1 China Sickle Cell Disease Treatment Market Size by Application (2018-2024)
8.3.2 China Sickle Cell Disease Treatment Market Size by Application (2024-2029)
8.3.3 China Sickle Cell Disease Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sickle Cell Disease Treatment Market Size (2018-2029)
9.2 Asia Sickle Cell Disease Treatment Market Size by Type
9.2.1 Asia Sickle Cell Disease Treatment Market Size by Type (2018-2024)
9.2.2 Asia Sickle Cell Disease Treatment Market Size by Type (2024-2029)
9.2.3 Asia Sickle Cell Disease Treatment Market Share by Type (2018-2029)
9.3 Asia Sickle Cell Disease Treatment Market Size by Application
9.3.1 Asia Sickle Cell Disease Treatment Market Size by Application (2018-2024)
9.3.2 Asia Sickle Cell Disease Treatment Market Size by Application (2024-2029)
9.3.3 Asia Sickle Cell Disease Treatment Market Share by Application (2018-2029)
9.4 Asia Sickle Cell Disease Treatment Market Size by Region
9.4.1 Asia Sickle Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Sickle Cell Disease Treatment Market Size by Region (2018-2024)
9.4.3 Asia Sickle Cell Disease Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.1.5 AstraZeneca Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.2.5 Eli Lilly Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Introduction
11.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Introduction
11.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.4.5 Pfizer Recent Developments
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Introduction
11.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.5.5 Baxter Recent Developments
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Details
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
11.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.6.5 Emmaus Life Sciences Recent Developments
11.7 Bluebird bio
11.7.1 Bluebird bio Company Details
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
11.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.7.5 Bluebird bio Recent Developments
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Details
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
11.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.8.5 Blood Therapeutics Recent Developments
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Details
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
11.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.9.5 Sangamo Therapeutics Recent Developments
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Details
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
11.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.10.5 Acceleron Pharma Recent Developments
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Details
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.11.5 Arena Pharmaceuticals Recent Developments
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Details
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.12.5 Alnylam Pharmaceuticals Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Sickle Cell Disease Treatment Introduction
11.13.4 Sanofi Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.13.5 Sanofi Recent Developments
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Details
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Introduction
11.14.4 CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.14.5 CRISPR Therapeutics Recent Developments
11.15 Vertex Pharmaceuticals, Inc.
11.15.1 Vertex Pharmaceuticals, Inc. Company Details
11.15.2 Vertex Pharmaceuticals, Inc. Business Overview
11.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Introduction
11.15.4 Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.15.5 Vertex Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Sickle Cell Anemia
Table 3. Key Players of Sickle Beta Thalassemia
Table 4. Key Players of Sickle Hemoglobin C Disease
Table 5. Global Sickle Cell Disease Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Sickle Cell Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sickle Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Sickle Cell Disease Treatment Market Share by Region (2018-2024)
Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sickle Cell Disease Treatment Market Share by Region (2024-2029)
Table 11. Sickle Cell Disease Treatment Market Trends
Table 12. Sickle Cell Disease Treatment Market Drivers
Table 13. Sickle Cell Disease Treatment Market Challenges
Table 14. Sickle Cell Disease Treatment Market Restraints
Table 15. Global Sickle Cell Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Sickle Cell Disease Treatment Revenue Share by Players (2018-2024)
Table 17. Global Top Sickle Cell Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Table 18. Global Sickle Cell Disease Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Sickle Cell Disease Treatment, Headquarters and Area Served
Table 21. Global Key Players of Sickle Cell Disease Treatment, Product and Application
Table 22. Global Key Players of Sickle Cell Disease Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Sickle Cell Disease Treatment Revenue Share by Application (2018-2024)
Table 30. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sickle Cell Disease Treatment Revenue Share by Application (2024-2029)
Table 32. North America Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Sickle Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Sickle Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Sickle Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Sickle Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Sickle Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Sickle Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Sickle Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Sickle Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Sickle Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Sickle Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Sickle Cell Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Sickle Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Sickle Cell Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Sickle Cell Disease Treatment Product
Table 67. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 68. AstraZeneca Recent Developments
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Sickle Cell Disease Treatment Product
Table 72. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 73. Eli Lilly Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Sickle Cell Disease Treatment Product
Table 77. Novartis Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Sickle Cell Disease Treatment Product
Table 82. Pfizer Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 83. Pfizer Recent Developments
Table 84. Baxter Company Details
Table 85. Baxter Business Overview
Table 86. Baxter Sickle Cell Disease Treatment Product
Table 87. Baxter Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 88. Baxter Recent Developments
Table 89. Emmaus Life Sciences Company Details
Table 90. Emmaus Life Sciences Business Overview
Table 91. Emmaus Life Sciences Sickle Cell Disease Treatment Product
Table 92. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 93. Emmaus Life Sciences Recent Developments
Table 94. Bluebird bio Company Details
Table 95. Bluebird bio Business Overview
Table 96. Bluebird bio Sickle Cell Disease Treatment Product
Table 97. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 98. Bluebird bio Recent Developments
Table 99. Blood Therapeutics Company Details
Table 100. Blood Therapeutics Business Overview
Table 101. Blood Therapeutics Sickle Cell Disease Treatment Product
Table 102. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 103. Blood Therapeutics Recent Developments
Table 104. Sangamo Therapeutics Company Details
Table 105. Sangamo Therapeutics Business Overview
Table 106. Sangamo Therapeutics Sickle Cell Disease Treatment Product
Table 107. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 108. Sangamo Therapeutics Recent Developments
Table 109. Acceleron Pharma Company Details
Table 110. Acceleron Pharma Business Overview
Table 111. Acceleron Pharma Sickle Cell Disease Treatment Product
Table 112. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 113. Acceleron Pharma Recent Developments
Table 114. Arena Pharmaceuticals Company Details
Table 115. Arena Pharmaceuticals Business Overview
Table 116. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
Table 117. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 118. Arena Pharmaceuticals Recent Developments
Table 119. Alnylam Pharmaceuticals Company Details
Table 120. Alnylam Pharmaceuticals Business Overview
Table 121. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
Table 122. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 123. Alnylam Pharmaceuticals Recent Developments
Table 124. Sanofi Company Details
Table 125. Sanofi Business Overview
Table 126. Sanofi Sickle Cell Disease Treatment Product
Table 127. Sanofi Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 128. Sanofi Recent Developments
Table 129. CRISPR Therapeutics Company Details
Table 130. CRISPR Therapeutics Business Overview
Table 131. CRISPR Therapeutics Sickle Cell Disease Treatment Product
Table 132. CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 133. CRISPR Therapeutics Recent Developments
Table 134. Vertex Pharmaceuticals, Inc. Company Details
Table 135. Vertex Pharmaceuticals, Inc. Business Overview
Table 136. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product
Table 137. Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 138. Vertex Pharmaceuticals, Inc. Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Sickle Cell Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Sickle Cell Anemia Features
Figure 4. Sickle Beta Thalassemia Features
Figure 5. Sickle Hemoglobin C Disease Features
Figure 6. Global Sickle Cell Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Sickle Cell Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Sickle Cell Disease Treatment Report Years Considered
Figure 12. Global Sickle Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Sickle Cell Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Sickle Cell Disease Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Sickle Cell Disease Treatment Market Share by Players in 2022
Figure 16. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2022
Figure 18. North America Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Sickle Cell Disease Treatment Market Share by Type (2018-2029)
Figure 20. North America Sickle Cell Disease Treatment Market Share by Application (2018-2029)
Figure 21. North America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 22. United States Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Sickle Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Sickle Cell Disease Treatment Market Share by Type (2018-2029)
Figure 26. Europe Sickle Cell Disease Treatment Market Share by Application (2018-2029)
Figure 27. Europe Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 28. Germany Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Sickle Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Sickle Cell Disease Treatment Market Share by Type (2018-2029)
Figure 36. China Sickle Cell Disease Treatment Market Share by Application (2018-2029)
Figure 37. Asia Sickle Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Sickle Cell Disease Treatment Market Share by Type (2018-2029)
Figure 39. Asia Sickle Cell Disease Treatment Market Share by Application (2018-2029)
Figure 40. Asia Sickle Cell Disease Treatment Market Share by Region (2018-2029)
Figure 41. Japan Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 51. Brazil Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 58. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 60. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 61. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 62. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 63. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 64. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 65. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 66. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 67. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 68. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 69. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 70. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 71. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed